BAY AREA TUMOR INSTITUTE CCOP

湾区肿瘤研究所 CCOP

• 批准号: 2091883
• 负责人: James Feusner
• 金额: $ 20.95万
• 依托单位: BAY AREA TUMOR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-06-25 至 1997-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2091883
• 关键词: African American; Asian Americans; Hispanic Americans; adult human (21+); cancer prevention; cancer rehabilitation /care; chemoprevention; child (0-11); clinical trials; combination cancer therapy; community health services; cooperative study; female; hospitals; human subject; human therapy evaluation; low socioeconomic status; neoplasm /cancer chemotherapy; neoplasm /cancer therapy; oncology; pediatric neoplasm /cancer; primary care physician

The Bay Area Tumor Institute Community Clinical Oncology Program (BATI- CCOP) is a consortium of five community and county hospitals in the Greater Oakland, California, area. It provides the community's cancer specialists, primary care physicians, and hospitals with a common clinical trials program. Integrating the goals of DHHS publication "Healthy People 2000" by targeting the minority, low income and female populations in Oakland, the BATI-CCOP enables cancer patients and the general population to participate in clinical research and cancer control research. During its first three years, the CCOP exceeded the NCI therapeutic accrual requirements by 29%, 61%, and 60% and will exceed both therapeutic and cancer control requirements for the current year by more than 50% each. Building on its achievements, the long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOP's, accrual of minority and pediatric patients at higher rates than all other CCOP's, accrual exceeding NCI's cancer control research requirements, increased interaction with research bases, and continued fulfillment of NCI's "Terms of Cooperation." The CCOP will accrue 95% of all eligible pediatric oncology patients in the region, accrue 50% of all eligible patients at the county hospital, and achieve minority and female participation that will exceed 75% of the total CCOP accrual. It will also maintain excellence in data management, timely submission of data, drug distribution, human subject review, and quality control. The Bay Area Tumor Institute will continue to commit $75,000 per year to the CCOP. The BATI-CCOP offers a successful track record, an organized community, experienced physician investigators, and unusual access to African American, Hispanic, Asian and female populations.

湾区肿瘤研究所社区临床肿瘤学项目(BATI- CCOP)是由五家社区和县医院组成的财团 大奥克兰，加利福尼亚州，地区。它提供了社区的癌症 专科医生、初级保健医生和具有共同临床特征的医院 试验计划。 将卫生部出版物《健康人2000》的目标整合到 针对奥克兰的少数民族、低收入和女性人口， BATI-CCOP使癌症患者和普通民众能够 参与临床研究和癌症控制研究。 在最初的三年里，CCOP超过了NCI治疗 应计需求分别增加29%、61%和60%，并将超过这两种治疗方法 和本年度癌症控制需求增加50%以上 每个人。在其成就的基础上，制定长期目标和具体目标 BATI-CCOP的目标包括在更高级别的治疗试验中获得收益 少数民族和儿科患者的应收率高于可比的CCOP 以比其他所有CCOP更高的比率，收益超过NCI的癌症 控制研究需求，增加与研究基地的互动， 继续履行NCI的《合作条款》。 CCOP将获得95%的符合条件的儿科肿瘤患者 该地区聚集了县医院所有合格患者的50%， 实现少数群体和女性参与率将超过75% CCOP应计总额。它还将在数据管理方面保持卓越， 及时提交数据、药品分配、人体受试者审查以及 质量控制。湾区肿瘤研究所将继续致力于 每年向CCOP支付75,000美元。 BATI-CCOP提供了一个成功的记录，一个有组织的社区， 经验丰富的内科医生调查人员，以及进入非洲的不同寻常的途径 美国人、西班牙人、亚洲人和女性人口。